Viewing Study NCT06608212


Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2026-06-23 @ 6:12 PM
Study NCT ID: NCT06608212
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-10
First Post: 2024-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Kidney Disease View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CKD View
None T2DM View